From obscurity to ‘superbug’ – The rise of Clostridium difficile

Thomas V. Riley

doi:10.1071/HI10028

EDITORIAL

Next Contents Vol 15(3)

From obscurity to ‘superbug’ – The rise of Clostridium difficile

Thomas V. Riley

+ Author Affiliations

- Author Affiliations

Microbiology & Immunology, The University of Western Australia and Division of Microbiology and Infectious Diseases, PathWest Laboratory Medicine (WA), Queen Elizabeth II Medical Centre, Nedlands 6009, WA, Australia. Email: triley@cyllene.uwa.edu.au

Healthcare Infection 15(3) 59-61 https://doi.org/10.1071/HI10028
Published: 22 September 2010

References

[1] Riley TV. Clostridium difficile: a pathogen of the nineties. Eur J Clin Microbiol Infect Dis 1998; 17 137–41.
| CAS | PubMed |

[2] Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002; 162 2177–84.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[3] Riley TV. Epidemic Clostridium difficile. Med J Aust 2006; 185 133–4.
| PubMed |

[4] Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353 2442–9.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[6] Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile – associated disease in nonsurgical inpatients. Clin Infect Dis 2008; 46 497–504.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[7] Kuijper EJ, van Dissel JT. Spectrum of Clostridium difficile infections outside health care facilities. CMAJ 2008; 179 747–8.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[8] Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhoea. Clin Infect Dis 1995; 20(Suppl 2): S263–5.
| PubMed |

[11] Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47 1162–70.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[12] Bauer MP , Notermans DW , van Benthem BHB , Wilcox MH , Monnet DL , van Dissel JT et al First results of the European Clostridium difficile infection survey (ECDros. Inf. Serv.), abstr. O-85. Abstract. 19th European Congress on Clinical Microbiology and Infectious Diseases. 2009.

[13] Riley TV, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. Med J Aust 2009; 191 706–8.

[14] Eggertson L. Quebec puts up $20 million for C. difficile fight. CMAJ 2005; 172 622.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[15] Office for National Statistics. 2009. Statistical bulletin. Deaths involving Clostridium difficile: England & Wales, 2008. Office for National Statistics, London, United Kingdom. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=14782.

[16] Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23 529–49.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |